Selective Wealth Management’s Boston Scientific BSX Stock Holding History

Selective Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-209	Closed	-$8K	–	198
2022 Q3	$8K	Hold	209	–	–	﹤0.01%	541
2022 Q2	$8K	Hold	209	–	–	﹤0.01%	580
2022 Q1	$9K	Hold	209	–	–	﹤0.01%	539
2021 Q4	$9K	Hold	209	–	–	﹤0.01%	492
2021 Q3	$9K	Hold	209	–	–	﹤0.01%	441
2021 Q2	$9K	Buy	+209	New	+$8.79K	0.01%	354

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Selective Wealth Management's BSX Position: Q4 2022 in Review

Selective Wealth Management sold out of Boston Scientific (BSX) in Q4 2022, closing a stake of 209 shares — an estimated $8K sold.

Selective Wealth Management first reported a position in BSX in Q2 2021 and held it in 6 quarters. The position peaked at $9K in Q1 2022. 928 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

Selective Wealth Management reported no remaining Boston Scientific position as of Q4 2022 after selling out during the quarter.
Selective Wealth Management sold 209 Boston Scientific shares in Q4 2022, an estimated $8K.
Selective Wealth Management first reported a position in Boston Scientific in Q2 2021 and held it in 6 quarters.
Selective Wealth Management's Boston Scientific position peaked at $9K in Q1 2022.
928 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Selective Wealth Management's 13F filing for Q4 2022, filed 23 Jan 2023.